Author(s)

Xueli Hu

Affiliation(s)

School of Information Engineering, Xuzhou University of Technology, Xuzhou 221018, China.

Corresponding Author

Xueli Hu

ABSTRACT

In recent years, more and more coronaviruses (CoV) have crossed the species barrier and spread from animals to humans, causing many serious public health events and causing huge losses to the global economy. Vaccination is currently the most effective measure to prevent the CoV pandemic, and a safe, efficient, and fast vaccine platform is the basis for vaccine research and development. With the increasing maturity of reverse genetics technology, it is also increasingly used in the development of CoV vaccines. This article reviews several reverse genetics techniques currently used in CoV research and their possible applications in the development of CoV vaccines.

KEYWORDS

Coronavirus; Reverse genetics; Vaccine.

CITE THIS PAPER

Xueli Hu. Application of reverse genetics in the development of coronavirus vaccine. Journal of Trends in Life Sciences. 2023, 1(1): 9-14.

REFERENCES

[1]World Health Organization. Coronavirus disease(COVID‐19) pan‐demic.(2023-05-10) [2023-05-10]. https://www.who.int/health‐topics/coronavirus#tab=tab_1.

[2] bhagat S, yadav N, shah J. Novel corona virus (CO‐VID ‐ 19 ) pandemic: current status and possible strategies for detection and treatment of the disease . Expert Rev Antiinfec ‐ tive Therapy, 2022, 20 ( 10 ): 1275‐ 1298.

[3] Hou YJ, Okuda K, Edwards CE. SARS‐CoV‐2 reve‐rse genetics reveals a variable infection gradient in the respiratory-tory tract. Cell, 2020, 182 (2): 429-446.

[4] Ehmann R, Kristenb C, Bankw B. Reverse genetics for type I feline coronavirus field isolate to study the molecular pathogenesis of feline infectious peritonitis. mBio, 2018, 9 (4): e01422‐18. DOI: 10.1128/mBio.01422‐18.

[5] Wang Mengjun, Shen Shuo. Research progress on non-structural proteins of coronavirus. Chinese Journal of Biological Products, 2022, 35 (1): 100‐111.

[6] Rawson JM, Duchon A, Nikolaitchik OA. Develo‐pment of a cell - based luciferase complementation assay for iden - tification of SARS - CoV - 2 3CLpro inhibitors. Viruses, 2021, 13 (2): e173. DOI:10. 3390/v13020173.

[7] Ye C, Chiem K, Park JG. Rescue of SARS - CoV - 2 from a single bacterial artificial chromosome. mBio, 2020, 11 (5): e02168-20. DOI: 10. 1128/mBio. 02168-20.

[8] Masters PS, Rottier P J. Coronavirus reverse genetics by Targeted RNA recombination. Curr Topics Microbiol and Im-munol, 2005, 287 (1): 133-159.

[9] Zhang QY, Deng CL, Liu J. SARS‐CoV‐2 replica for high‐throughput antiviral screening. J General Virol, 2021, 102 (5): e001583. DOI: 10.1099/jgv.0.001583.

[10] Ju X, Zhu Y, Wang Y. A novel cell culture system mod ‐eling the SARS‐CoV‐2 life cycle. PLoS Pathog, 2021, 17 (3): e1009439. DOI: 10. 1371/journal.ppat.1009439.